Used in pharmaceutical research as a key intermediate in the synthesis of kinase inhibitors, particularly for targeted cancer therapies. Its structure enables selective modification for optimizing drug potency and bioavailability. Commonly employed in cross-coupling reactions, such as Suzuki-Miyaura, to introduce aryl or heteroaryl groups during the development of bioactive molecules. Also utilized in the preparation of pyrrolopyridine-based compounds with potential antitumor and anti-inflammatory activities.